What is the Evidence for Using Intranasal Medicine in the Prehospital Setting? A Systematic Review.
Prehospital Emergency Care · 2024-01-01 · Systematic review
Abstract
OBJECTIVES: Intranasal (IN) medications offer a safe non-invasive way to rapidly deliver drugs in situations where intravenous (IV) access and intramuscular (IM) administration is challenging or not feasible. In the prehospital setting, this can be an essential alternative in time critical situations including trauma management, seizures, and agitated patients. However, there is a paucity of evidence summarizing its efficacy in this environment. This systematic review aims to assess the current evidence supporting the use of IN medicine (midazolam, ketamine, fentanyl, morphine, glucagon, and naloxone) in the prehospital setting alone. METHODS: A systematic literature search (PROSPERO CRD42023440713) of PubMed, Web of Science, OVID Medline, "Cochrane Central Register of Controlled Trials," Cochrane reviews and Embase was performed from inception to June 2023 to identify studies where IN medications were administered to patients in the prehospital setting. All randomized controlled trials, observational cohort studies, case series, and case reports were included. Papers not written in English, review articles, abstracts, and non-published data (including letters to the editor) were excluded. The methodological quality of the included studies was interpreted using the Cochrane risk of bias tool and rated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. No funding was received. RESULTS: From 4818 studies, 39 were included (seven for midazolam, five for ketamine, twelve for fentanyl, one for diamorphine, two for glucagon, and twelve for naloxone). A total of 24,097 patients were treated with IN medications across all the studies. There were five moderate quality, four low quality, and thirty very low quality studies. The potential efficacy of IN fentanyl and ketamine was demonstrated consistently throughout the studies with less clear evidence for midazolam, morphine, glucagon, and naloxone. This review was severely limited by the study quality, with most studies demonstrating "high concerns" for bias. CONCLUSIONS: Prehospital IN medication administration has wide-ranging potential, particularly for administering analgesia. There are likely to be certain populations, for example, pediatrics, that will benefit the most, although conclusions are limited by the quality of evidence currently available. We encourage additional research in this area, particularly with robust prospective double-blind RCTs.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Analgesics · Intranasal administration · Glucagon · Morphine · Anaesthetics · Sedatives & anxiolytics · Ketamine · Fentanyl · Midazolam · Antidotes · Naloxone
Related articles
- Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings. (Am J Health Syst Pharm, 2015)
- When to Pick the Nose: Out-of-Hospital and Emergency Department Intranasal Administration of Medications. (Ann Emerg Med, 2017)
- An Analysis of Prehospital Pediatric Medication Dosing Errors after Implementation of a State-Wide EMS Pediatric Drug Dosing Reference. (Prehosp Emerg Care, 2024)
- Stability of Drugs Stored in Helicopters for Use by Emergency Medical Services: A Prospective Observational Study. (Ann Emerg Med, 2022)
- Ketamine Use in Operation Enduring Freedom. (Mil Med, 2021)
- Review of therapeutic agents employed by an Australian aeromedical prehospital and retrieval service. (Emerg Med Australas, 2016)